Becton Dickinson and Company (BDX)
NYSE: BDXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BDX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $49.07B
- P/E (TTM)
- 41.90
- Forward P/E
- 13.54
- EPS (TTM)
- $4.30
- Dividend yield
- 2.33% ($4.19)
- Ex-dividend date
- Sep 9, 2026
- 52-week range
- 127.59 – 193.07
- Day range
- 177.92 – 182.30
- Volume / Avg
- 1.91M / 1.78M
- Beta
- —
- Shares outstanding
- 272.39M
- Next earnings
- Nov 5, 2026
52-week range
BDX stock today
On Oct 7, BDX ended the session at $180.16, shedding $0.14 (0.08%), versus the S&P 500's 0.22% decline. At this level, BDX sits near the top of its 52-week range of $127.59 to $193.07: 6.7% below the high, set on Aug 24, 2026 and 41.2% above the low. BDX is up 18.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 19.0%.
At 41.9x trailing earnings, Becton Dickinson trades above the peer-group median of 31.1x. Its forward P/E of 13.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Becton Dickinson's next earnings report is expected on Nov 5, 2026. Becton Dickinson pays an annual dividend of $4.19 per share, a 2.33% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Becton Dickinson
Company profileBecton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Thomas E. Polen Jr.
- Headquarters
- Franklin Lakes, NJ
- Employees
- 72,000
- Website
- bd.com
Financial highlights
Full financialsIn fiscal 2025, Becton Dickinson generated $21.84 billion in revenue, up 8.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $1.68 billion (-1.6% year over year), for a net margin of 7.7% versus a median of 8.4% in the prior 5 years. Gross margin was 45.4% (up from 45.2%) and operating margin 11.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B |
| Growth | +8.24% | +4.16% | +2.66% | -1.36% | +19.02% |
| Net income | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B |
| EPS (diluted) | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 |
Analyst forecast
ForecastConsensus (15 analysts)
buy
Avg. price target
$194.08+7.73%
- Strong buy 1
- Buy 6
- Hold 7
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $4.06
- Last reported (Q3 2026)
- Aug 6, 2026
- EPS actual vs est.
- $1.37 vs —
Dividends
Dividend history- Annual dividend
- $4.19
- Dividend yield
- 2.33%
- Last payment
- $1.05
- Ex-dividend date
- Sep 9, 2026
BDX news
All BDX news- BDX Expands U.S. Manufacturing With $19B Healthcare InvestmentNasdaqBDX, WST, OPK, GMED
- Becton, Dickinson Partners With U.S. Govt. To Expand Domestic Manufacturing, To Invest $19 BlnNasdaq
- Trump: Becton Dickinson agrees to invest $3B in US manufacturing, including $1B+ in NebraskaSeeking Alpha
- Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDexNasdaqBDX, CAH, MCK, MMSI
- QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared PanelNasdaqQGEN, BDX, TMO, BRKR
- 5 Medical Dental Supply Stocks to Watch as Industry Prospects ImproveNasdaqMCK, BDX, CAH, MMSI
- Here's Why You Should Retain BDX Stock in Your Portfolio for NowNasdaqBDX, WST, GMED, VCYT
- BDX Deploys Vmax 160 to Advance Intelligent Pharmacy AutomationNasdaqBDX, WST, GMED, VCYT
Becton Dickinson peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MDLNMedline Inc. Class A | 35.45 | -0.28% | $47.70B | vs BDX |
| BSXBoston Scientific Corporation | 41.58 | -1.45% | $60.26B | vs BDX |
| DXCMDexCom Inc. | 84.30 | +1.09% | $31.81B | vs BDX |
| RMDResMed Inc. | 225.98 | +2.40% | $31.78B | vs BDX |
| WSTWest Pharmaceutical Services Inc. | 366.48 | -1.65% | $25.79B | vs BDX |
| SOLVSolventum Corporation | 85.88 | -1.33% | $14.62B | vs BDX |
| MMM3M Company | 162.12 | -0.93% | $83.61B | vs BDX |
| PENPenumbra Inc. | 316.35 | -0.22% | $12.46B | vs BDX |
Indexes, lists and sector
Index membership
Appears in lists
Becton Dickinson stock FAQ
What is Becton Dickinson's stock price today?
BDX last traded at $180.16 as of Oct 7, 4:00 PM EDT, down 0.08% on the day. Prices are delayed at least 15 minutes.
Does Becton Dickinson pay a dividend?
Yes. Becton Dickinson pays $4.19 per share annually, a 2.33% yield. The most recent dividend of $1.05 had an ex-dividend date of Sep 9, 2026.
When is Becton Dickinson's next earnings date?
Becton Dickinson is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $4.06.
What is BDX's P/E ratio?
BDX trades at a trailing P/E ratio of 41.90 and a forward P/E of 13.54, compared with a median of 31.1 for its closest peers.
Is Becton Dickinson in the S&P 500?
Yes. Becton Dickinson (BDX) is a constituent of the S&P 500 index.
Who is Becton Dickinson's CEO?
Mr. Thomas E. Polen Jr. is the chief executive officer of Becton Dickinson and Company, which has about 72,000 employees.
Has BDX ever split its stock?
Yes. The most recent BDX stock split was a 1272-for-1000 split on Feb 10, 2026, one of 6 splits on record.